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0929-6441/ª 2016, Elsevier Taiwan LL
BY-NC-ND license (http://creativecomAbstract Spontaneous intrahepatic porto-systemic shunts (IHPSS) can be disclosed with ul-
trasound (US) and color Doppler ultrasound (CDU). However, direct evidence of the shunt on
US or CDU may not be convincing. In this report we demonstrate the presence of IHPSS by ul-
trasonic contrast portography with intravenous injection of microbubble-based contrast agent
(MBCA). With this technique, the MBCA was depicted to enter the hepatic vein through the
shunt, and then flowed into the inferior vena cava.
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Spontaneous shunt between portal veins and hepatic portal
and hepatic veins, an intrahepatic vascular malformation,
is a rare disease entity [1e7]. Early diagnosis is important
to prevent hepatic encephalopathy and hematemsis. Fewer
than 50 cases of spontaneous intrahepatic porto-systemic
shunts (IHPSS) have been reported in the literature
[6e11]. IHPSS may be disclosed with ultrasound (US) or
color Doppler ultrasound (CDU) [10e12]. However, direct
evidence of IHPSS on US or CDU may not be convincing. Inf Ultrasound in Medicine. This is an open access article under the CC
).
Figure 1 Gray-scale and color Doppler US studies of the liver.
(A) Gray-scale US of the right hepatic lobe (intercostal scan)
demonstrates a venous structure which is suspected to run in a
curved course (arrows), and connection between a portal
branch and a hepatic vein is possible; (B) color Doppler US
depicts a possible communication (arrowhead) between a
branch of the right portal vein (small arrows) and the right
hepatic vein (large arrows). However, the continuity of the
vessels cannot be well portrayed. US Z ultrasound.
26 Y.-H. Chou et al.this report we demonstrate the IHPSS by using ultrasonic
contrast portography with intravenous injection of micro-
bubble contrast agent (MBCA).
Techniques
A suspension of galactose microparticles in distilled water
(Levovist; Schering, Berlin, Germany) was used as an MBCA.
The microbubbles formed after vigorous shaking of the
microparticle suspension for 10 seconds are estimated to
have an average diameter of 2e8 mm. A total of 2.5 g of
levovist in a concentration of 300 mg/Ml (8 mL) was injec-
ted manually at a speed of 1 mL/s through a 20-gauge
cannula inserted in the antecubital vein, and was flushed
with an additional 10 mL of normal saline. A US study was
performed using a Logiq 9 scanner (GE Medical System,
Milwaukee, WI, USA) equipped with coded harmonic func-
tion. A 24-MHz curved linear array broadband transducer
was used. The mechanical index was set at 0.60.8. Before
the contrast study, a routine fundamental hepatic sonog-
raphy was performed to demonstrate the location with
suspected abnormal vasculature. The best scanning plane
was chosen, and then the coded harmonic US function was
switched on. Ten seconds after injection of Levovist sus-
pension the patient was instructed to hold his breath so
that the blood flows in the vessels of the porta hepatics
enhanced by the MBCA could be continuously monitored
and the suspected abnormality could be traced. The whole
course of the US contrast study was recorded with a
compact disk recorder.
Illustration of a case
A 70-year-old man was admitted with the chief complaints
of abdominal fullness and two episodes of passage of tarry
stool in the past month. The past history was unremarkable
except for occasional nose bleeds. On physical examina-
tion, he had anemic conjunctivae and a few telangiectasis
on the tongue, lips, nasal septum, and the turbinates
bilaterally. He had a regular pulse with a Grade 2/6 pre-
cordial systolic murmur on auscultation. The vertical span
of the right hepatic lobe was w15 cm on percussion, indi-
cating mild hepatomegaly. The other parts of abdomen
were otherwise normal. The laboratory values were within
normal range except for a minimally elevated alkaline
phosphotase (220 IU/L) and alanine aminotransferase
(52 IU/L). To investigate the cause of hepatomegaly, a US
study of the upper abdomen was undertaken, which dis-
closed dilated common hepatic artery (maximal diameter:
8.5 mm). Multiple tortuous tubular structures representing
vascular channels in the right hepatic lobe were noticed.
By careful US tracing and color Doppler US evaluation of
the right lobe vessels, communication between the right
portal branch and the right hepatic vein through these
vascular channels was suspected (Figure 1). Based on the
clinical manifestations and US findings of the liver, a
diagnosis of OsbereWebereRendu disease (OWRD) was
made. The liver pathology was attributed to IHPSS. To
verify the existence of shunting, intravenous ultrasonic
contrast portography was done. Cloud-like contrast-
enhanced blood flow was demonstrated in the right portalbranch. Via the communicating collateral venous channels,
the enhanced blood ran toward the right hepatic vein and
then to the inferior vena cava (Figure 2). A diagnosis of
hepatic angiodysplasia with IHPSS was confirmed on the
basis of intravenous ultrasonic contrast portographic find-
ings. The patient was therefore treated conservatively for
his gastrointestinal bleeding, and has been doing well since
then for 3 years.Discussion
The cause of IHPSS is still unclear. It has been contributed
to injury, congenital malformations, or collaterals as a
result of portal hypertension such as in cirrhosis of the liver
and BuddeChiari syndrome [10e13]. Patients with SPVS can
be asymptomatic and their vascular abnormalies are inci-
dentally found during abdominal imaging. However, several
clinical manifestations can be present at the time of diag-
nosis, including hematemesis, ascites, abnormal behavior,
Figure 2 Contrast-enhanced US after intravenous MBCA in-
jection. (A) 16 seconds after injection: the right portal branch
(arrows) is enhanced; (B) 18 seconds after injection: the he-
patic vein (large arrow) and the inferior vena cava (IVC) lumens
are enhanced by the microbubbles and become echogenic. The
continuity of the vessels is well shown. MBCA Z microbubble-
based contrast agent.
Spontaneous Intrahepatic Porto-systemic Shunt 27loss of consciousness, and flapping tremor. Some of the
latter symptoms are related to hepatic coma [14e16]. The
most commonly reported cases with symptoms usually have
a single large tube of constant diameter that connects the
right portal vein to the inferior vena cava [6]. This is the
most common type and has been classified as Type I IHPSS.
There are some other morphological types of IHPSS. The
second type is a localized peripheral shunt in which single
or multiple communications are found between peripheral
branches of the portal and hepatic veins in one segment
[15]. The third type presents as an aneuysmal fistula be-
tween the communicated portal and hepatic veins [17]. The
fourth type has multiple communications between periph-
eral portal and hepatic veins diffusely in both lobes of the
liver [6]. Our cases correspond to the first type. Recognition
of this sort of vascular malformation is therefore of clinical
importance because there could be significant clinical
symptoms developed during the patient’s lifetime.
The hepatic vasculature is best evaluated with conven-
tional or substraction iodinated contrast angiography. Since
the development of cross-sectional imaging modalities such
as computed tomography (CT), US, and magnetic resonanceimaging (MRI), noninvasive demonstration of the hepatic
vasculature has been made possible. These techniques, also
referred to as CT angiography, MR angiography, and ultra-
sonic angiography in their state-of-the-art functions have
been applied in clinical studies of the visceral vessels
[18e23]. Among these, US in conjunction with various
Doppler technologies is the most convenient method in the
evaluation of hepatic vasculature [23,24]. Power Doppler US
may provide more information regarding the shunts between
hepatic arteries and veins, and better demonstration of
dilated and tortuous hepatic arteries [5]. In the present
case, the dilated communicating venous channels between
the portal veins and the hepatic vein can be traced with
real-time US and demonstrated clearly with power Doppler
US. In patients with IHPSS, the dilated feeding hepatic ar-
tery in the hepato-duodenal ligament and porta hepatis may
mimic a dilated biliary duct sonographically. Similarly, the
dilated communicating venous channel can be also mistaken
as dilated intrahepatic bile ducts, the so-called too-many-
tubes sign. Color Doppler and/or power Doppler US can
portray color flow signals in the aforementioned dilated
artery or venous channels Doppler. Power Doppler is
particularly good for delineation of the vascular course in a
more continuous fashion [5]. However, in some vascular
channels when the vessels are extremely tortuous or inter-
vening, color Doppler and power Doppler US may have dif-
ficulty in demonstrating the relationship of the closely
arranged vessels. Iodinated contrast venography is the gold
standard in this instance. With the recent advent of ultra-
sonic contrast agents, it is possible to perform contrast-
enhanced ultrasonography (CEUS) via intravenous route
and to observe the echo-enhancing effect in the target or-
gans or pathologies [25e27]. CEUS can also be used to
evaluate the transjugular intrahepatic portosystemic shunt
(TIPS) and its complication [28]. Levovist, a galatose-based
contrast agent, can enter the portal vein via the systemic
circulation w15e20 seconds after intravenous administra-
tion of the levovist suspension solution. The vasculature of
hepatic tumors may be significantly enhanced with intra-
venous MBCA [26,27]. In this paper, CEUS by injection of
MBCA into the autecubital vein demonstrated MBCA flowed
into the right portal branch, the shunts, and the drainage
hepatic veins and IVC were all enhanced with echogenic
microbubbles. The direct demonstration of the communi-
cation enhanced the diagnostic confidence of IHPSS for some
patients in whom noninvasive imaging may not be conclu-
sive. This minimally invasive method can be safely moni-
tored under real-time US [29].References
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